Related Experiment Video
Updated: Mar 30, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs
Scot J Matkovich1, Gerald W Dorn2, Tiffani C Grossenheider2
1From the Department of Internal Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO. smatkovi@dom.wustl.edu.
Background:
MicroRNAs are key players in cardiac stress responses, but the mRNAs, whose abundance and translational potential are primarily affected by changes in cardiac microRNAs, are not well defined. Stimulus-induced, large-scale alterations in the cardiac transcriptome, together with consideration of the law of mass action, further suggest that the mRNAs most substantively targeted by individual microRNAs will vary between unstressed and stressed conditions. To test the hypothesis that microRNA target profiles differ in health and disease, we traced the fate of empirically determined miR-133a and miR-378 targets in mouse hearts undergoing pressure overload hypertrophy.
Methods And Results:
Ago2 immunoprecipitation with RNA sequencing (RNA-induced silencing complex sequencing) was used for unbiased definition of microRNA-dependent and microRNA-independent alterations occurring among ≈13 000 mRNAs in response to transverse aortic constriction (TAC). Of 37 direct targets of miR-133a defined in unstressed hearts (fold change ≥25%, false discovery rate <0.02), only 4 (11%) continued to be targeted by miR-133a during TAC, whereas for miR-378 direct targets, 3 of 32 targets (9%) were maintained during TAC. Similarly, only 16% (for miR-133a) and 53% (for miR-378) of hundreds of indirectly affected mRNAs underwent comparable regulation, demonstrating that the effect of TAC on microRNA direct target selection resulted in widespread alterations of signaling function. Numerous microRNA-mediated regulatory events occurring exclusively during pressure overload revealed signaling networks that may be responsive to the endogenous decreases in miR-133a during TAC.
Conclusions:
Pressure overload-mediated changes in overall cardiac RNA content alter microRNA targeting profiles, reinforcing the need to define microRNA targets in tissue-, cell-, and status-specific contexts.
Insights
Cardiac microRNA targeting shifts significantly during pressure overload. Understanding these changes is crucial for defining microRNA roles in heart disease and developing targeted therapies.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are critical regulators of cardiac stress responses.
- The specific messenger RNAs (mRNAs) affected by cardiac miRNAs under stress are not fully understood.
- Cardiac transcriptome-wide changes suggest miRNA targeting may differ between healthy and stressed states.
Purpose of the Study:
- To investigate how microRNA target profiles change in mouse hearts during pressure overload hypertrophy.
- To test the hypothesis that miRNA targeting differs between unstressed and stressed cardiac conditions.
Main Methods:
- Utilized Ago2 immunoprecipitation followed by RNA sequencing (RISC-seq) to unbiasedly identify miRNA-dependent and -independent mRNA alterations.
- Analyzed approximately 13,000 mRNAs in response to transverse aortic constriction (TAC).
Main Results:
- During TAC, only 11% of miR-133a direct targets and 9% of miR-378 direct targets remained significantly regulated.
- Widespread alterations in signaling function were observed due to changes in miRNA direct target selection during TAC.
- Identified novel miRNA-mediated regulatory events specific to pressure overload conditions.
Conclusions:
- Pressure overload significantly alters microRNA targeting profiles in the cardiac tissue.
- The findings underscore the necessity of defining miRNA targets within specific tissue, cell, and physiological contexts for accurate understanding of cardiac function and dysfunction.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Pharmacogenomics: Identification of New Drug Targets

